Keyphrases
Cystic Fibrosis
100%
Pseudomonas Aeruginosa (P. aeruginosa)
100%
Cytokine Response
100%
Tobramycin
100%
Inhaled Tobramycin
100%
Systemic Cytokine
100%
Off Therapy
83%
Lung Clearance Index
33%
Nineteen
16%
Interleukin-6
16%
Body Mass Index
16%
Parameter Change
16%
Small Sample Size
16%
Interleukin-8
16%
Treatment Duration
16%
High-sensitivity C-reactive Protein (hs-CRP)
16%
Inflammatory Cytokines
16%
Treatment Strategy
16%
Laboratory Parameters
16%
Relative Stability
16%
Neutrophil Elastase
16%
Off Periods
16%
Multiple Parameters
16%
Prospective pilot Study
16%
Spirometry
16%
Antitrypsin
16%
Systemic Inflammation Response Index
16%
Alternate Therapy
16%
Spirometry Parameters
16%
Pseudomonas Aeruginosa Colonization
16%
Serum IL-6
16%
Degree of Inflammation
16%
Lung Function Parameters
16%
Nebulized Therapy
16%
Days of Treatment
16%
Treatment Cycle
16%
Medicine and Dentistry
Pseudomonas aeruginosa
100%
Cytokine Response
100%
Patient with Cystic Fibrosis
100%
Tobramycin
100%
Cystic Fibrosis
62%
Interleukin-6
25%
Spirometry
25%
Lung Clearance
25%
Body Mass Index
12%
Tumor Necrosis Factor
12%
Inflammatory Cytokine
12%
Elastase
12%
Trypsin Inhibitor
12%
Nebulizer
12%
Pharmacology, Toxicology and Pharmaceutical Science
Cystic Fibrosis
100%
Cytokine
100%
Pseudomonas aeruginosa
100%
Tobramycin
100%
Tumor Necrosis Factor
12%
Elastase
12%
Trypsin Inhibitor
12%
Inflammation
12%
Nebulizer
12%
Immunology and Microbiology
Cytokine Response
100%
Powder
100%
Pseudomonas aeruginosa
100%
Interleukin-6
33%
Lung Clearance
33%
Tumor Necrosis Factor
16%
Inflammatory Cytokine
16%
Body Mass
16%
Sample Size
16%